101477-46-7 Usage
Uses
Used in Pharmaceutical Industry:
1-(2,4-dimethoxybenzyl)-4-[(4-fluorophenyl)(phenyl)methyl]piperazine (2E)-but-2-enedioate is used as a potential pharmaceutical compound for its possible biological activity. 1-(2,4-dimethoxybenzyl)-4-[(4-fluorophenyl)(phenyl)methyl]piperazine (2E)-but-2-enedioate's structure suggests that it may interact with various biological targets, potentially leading to the development of new drugs for treating various diseases.
Used in Research and Development:
In the field of chemical research, 1-(2,4-dimethoxybenzyl)-4-[(4-fluorophenyl)(phenyl)methyl]piperazine (2E)-but-2-enedioate serves as a valuable compound for studying its interactions with different biological systems. Understanding these interactions can provide insights into the compound's potential applications and help in the design of new molecules with improved properties.
Used in Drug Design and Synthesis:
1-(2,4-dimethoxybenzyl)-4-[(4-fluorophenyl)(phenyl)methyl]piperazine (2E)-but-2-enedioate's unique structure makes it a useful building block in the design and synthesis of new drugs. Researchers can use 1-(2,4-dimethoxybenzyl)-4-[(4-fluorophenyl)(phenyl)methyl]piperazine (2E)-but-2-enedioate as a starting point to create novel molecules with enhanced properties, such as increased potency, selectivity, or reduced side effects. This can lead to the development of more effective treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 101477-46-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,4,7 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 101477-46:
(8*1)+(7*0)+(6*1)+(5*4)+(4*7)+(3*7)+(2*4)+(1*6)=97
97 % 10 = 7
So 101477-46-7 is a valid CAS Registry Number.
101477-46-7Relevant academic research and scientific papers
1-(2,3,4-tri-methoxybenzyl)-4[bis(4-fluorophenyl)methyl] piperazines are useful for treating cerebrovascular disease
-
, (2008/06/13)
A 1-benzyl-4-benzhydrylpiperazine derivative represented by the following general formula (I) STR1 wherein R1 represents a hydrogen atom or a methoxy group, and R2 represents a hydrogen or fluorine atom, or a pharmaceutically acceptable acid addition salt thereof. The 1-benzyl-4-benzhydrylpiperazine derivative or an acid addition salt thereof is prepared by reductively condensing a benzaldehyde derivative with a fluorobenzhydrylpiperazine, or condensing a benzyl halide derivative with a fluorobenzhydrylpiperazine optionally in the presence of an acid acceptor, or condensing a benzylpiperazine with a fluorobenzhydryl halide derivative and, optionally converting the product to its acid addition salt. The 1-benzyl-4-benzhydrylpiperazine derivative is useful for improving a cerebrovascular disease.
